Braidwell LP Purchases Shares of 14,040 Waters Corporation $WAT

Braidwell LP purchased a new position in shares of Waters Corporation (NYSE:WAT) during the 2nd quarter, Holdings Channel.com reports. The fund purchased 14,040 shares of the medical instruments supplier’s stock, valued at approximately $5,266,000.

A number of other institutional investors have also modified their holdings of WAT. Anchor Investment Management LLC acquired a new stake in Waters during the first quarter worth about $27,000. Resources Management Corp CT ADV purchased a new position in Waters during the first quarter valued at approximately $27,000. PenderFund Capital Management Ltd. acquired a new position in Waters in the second quarter valued at approximately $28,000. Zions Bancorporation National Association UT lifted its holdings in Waters by 121.2% in the fourth quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 40 shares during the period. Finally, Vision Retirement LLC purchased a new stake in Waters in the 1st quarter worth approximately $29,000. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Insider Buying and Selling

In related news, Director Christopher A. Kuebler sold 3,626 shares of the business’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $397.94, for a total value of $1,442,930.44. Following the completion of the sale, the director owned 17,808 shares of the company’s stock, valued at approximately $7,086,515.52. The trade was a 16.92% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.31% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on WAT. Citigroup raised their price objective on shares of Waters from $425.00 to $470.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. Royal Bank Of Canada boosted their target price on shares of Waters from $435.00 to $475.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. The Goldman Sachs Group increased their price target on shares of Waters from $380.00 to $425.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. UBS Group raised their price target on shares of Waters from $330.00 to $375.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Finally, TD Cowen raised shares of Waters from a “hold” rating to a “buy” rating and lifted their price objective for the company from $408.00 to $475.00 in a report on Wednesday, August 5th. Three research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $424.35.

Waters Stock Up 1.6%

Shares of WAT opened at $412.15 on Thursday. The company has a current ratio of 1.86, a quick ratio of 1.29 and a debt-to-equity ratio of 0.32. Waters Corporation has a 12 month low of $282.77 and a 12 month high of $426.22. The stock’s 50 day moving average is $390.51 and its two-hundred day moving average is $350.41. The firm has a market cap of $40.49 billion, a P/E ratio of 102.78, a PEG ratio of 2.36 and a beta of 1.19.

Waters (NYSE:WAT) last announced its earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share for the quarter, topping the consensus estimate of $3.01 by $0.04. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.62 billion. Waters had a return on equity of 11.27% and a net margin of 3.58%.The business’s quarterly revenue was up 113.3% on a year-over-year basis. During the same period in the prior year, the company posted $2.95 EPS. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Analysts predict that Waters Corporation will post 14.56 earnings per share for the current fiscal year.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.